Ultrasound-Indicated Cervical Cerclage Efficacy Between 16 and 28 Weeks of Gestation in Twin Pregnancy: Retrospective Cohort Study.

Objective: The aim of this study is to determine if cervical cerclage administration reduces the preterm birth (PTB) rate at a gestational age (GA) of 16-28 weeks in women with twin pregnancy.
Methods: This is a retrospective cohort study on asymptomatic twin pregnancy with an ultrasound-identified cervix length (CL) of ≦25 mm. The patients were divided into two groups: ultrasound-indicated cerclage (UIC) group and control (expectant management) group. The primary outcome was a PTB rate at <34 weeks. A logistic regression was also performed, and a subgroup analysis stratified by CL and GA at first short cervix diagnosis was planned.
Results: In all 320 women, there were no differences in the overall <34-week PTB rates and neonatal outcomes between the UIC group and control group. After performing a multivariate logistic regression analysis, the subgroup analyses were planned. In patients with a CL of ≦15 mm, the <34-week PTB rate was significantly decreased in the UIC subgroup compared with the control subgroup (60.78% vs 78.26%; odds ratio (OR) = 0.43, confidence interval (CI) = 95% [0.22-0.86]; and p = 0.020). In patients with a first short cervix diagnosis GA of ≦24 weeks, the <34-week PTB rate was significantly decreased in the UIC subgroup when compared with the control subgroup (61.54% vs 84.75%; OR = 0.29; CI = 95% [0.13-0.63]; and p = 0.001). Furthermore, compared with the control groups, the UIC groups had higher mean birth weight, lower perinatal mortality, and lower NICU admission, and the differences were statistically significant.
Conclusion: UIC could significantly reduce the <34-week PTB rate and improve perinatal outcomes in patients with a CL of ≦15mm or first short cervix diagnosis GA of ≦24 weeks with asymptomatic twin pregnancy during the second trimester.

Introduction

Despite significant improvements in prenatal and neonatal care over the last decades, preterm birth (PTB) is the world’s leading neonatal death cause.1 Moreover, children who survive PTB may face the risk of lifelong disability, including vision and hearing loss, cerebral palsy, intellectual impairment, and chronic lung disease.2 They are also at greater risk of developing hypertension, diabetes, and developmental problems later in life than other children.2 In recent years, the twin pregnancy incidence has increased dramatically due to widespread use of assisted reproductive technology as well as the rise in maternal age. As a result, PTB occurrence is five times greater in twin gestations than in singleton gestations; almost 60% of twins are born at a GA of <37 weeks, and up to 21.2% are born at a GA of <34 weeks.3

The presence of a short cervix, which is defined by a transvaginal sonographic cervical length (CL) of ≦25 mm (measured in the second trimester of pregnancy) is a primary risk factor for spontaneous PTB; it has become one of the strongest and most consistent PTB predictors in asymptomatic women with singleton and twin gestation.4–7 Cervical cerclage is a well-known surgical procedure performed during pregnancy; it provides mechanical support to the cervix, thereby decreasing the risk of PTB.8 Cerclage placement in patients with singleton gestation, a history of spontaneous PTB, and a short cervix at a GA of <24 weeks has been found to decrease the respective incidence rates of PTB and perinatal mortality.9

However, the effectiveness of cervical cerclage placement in twin pregnancy remains controversial. From 2013 to 2015, the early years of several related research showed no significant difference between using and not using cervical cerclage in twin pregnancy. However, several recent retrospective studies have shown a potentially positive effect of cerclage placement in twin pregnancy in patients with a short cervix at a GA of <24 weeks. In their study, Huang et al stated that cerclage appears to be beneficial in patients with a history of preterm labor, a very short cervix, or cervical dilation. Certain studies also found that cerclage placement significantly reduced the twin pregnancy PTB rate in women with a very short cervix (<10 mm or <15 mm); therefore, it may be effective in certain patients with twin gestation.

Cervical cerclage placement in women with a twin pregnancy is not a routine practice, and its indication is not universally accepted. It is still unknown whether cervical cerclage use is required in asymptomatic twin pregnancy with only a short cervix diagnosis at a GA of either <24 weeks or >24 weeks. The purpose of the present study is to evaluate ultrasound-indicated cerclage (UIC) (CL ≦ 25 mm) efficacy in women with twin pregnancy and no history of preterm labor; comparisons will also be made with women who were managed expectantly in relation to pregnancy and perinatal outcomes.

Materials and Methods

Patients and Study Design

The present research is a retrospective cohort study of twin pregnancy in subjects examined throughout pregnancy and delivery at Shanghai First Maternity and Infant Hospital affiliated to Tongji University between January 2014 and December 2020. The subjects had a CL of ≦25 mm (measured via transvaginal ultrasound [TVU]) at a GA of 16–28 weeks. Exclusion criteria: (1) subjects with genetic or major fetal anomalies; (2) subjects with monochorionic-monoamniotic placentation; (3) subjects who underwent elective pregnancy termination; (4) subjects with a history of PTB, cerclage, or medically indicated PTB (eg, twin-to-twin transfusion syndrome, severe preeclampsia, abruption placenta, placenta previa, and active vaginal bleeding); and (5) subjects with history-indicated or physical-indicated cerclage. The participants’ flow chart is showed in Figure 1.

Figure 1

The participants’ flow chart.

Shanghai First Maternity and Infant Hospital has two districts: the eastern district and the western district. In the eastern district, women pregnant with twins who had a CL of ≦25 mm (UIC group) were routinely treated with cerclage; in contrast, women in the western district who were pregnant with twins and had a CL of ≦25 mm (control group) were managed expectantly. Apart from cerclage, there were no differences in medical treatments for threatened abortion between the two groups.

The present retrospective study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Shanghai First Maternity and Infant Hospital (No. KS20186), and written informed consent was obtained from all study participants.

Clinical Treatment

All patients in the UIC group underwent a McDonald cerclage; they preoperatively received antibiotic prophylaxis (cefazolin or clindamycin in subjects allergic to penicillin), and a standardized transvaginal McDonald’s technique for cervical cerclage was performed. All procedures were conducted by two experienced senior physicians, and the patients were under general anesthesia during the procedure. No routine tocolytic therapy or post-procedural prophylactic antibiotic therapy was provided; all women were discharged 24–48 h after cerclage placement. A dosage of 200 mg adjunctive vaginal progesterone was administered daily for 7 consecutive days after cerclage. The cerclage was removed at a GA of 37 weeks or in the case of a Cesarean section if indicated.

All patients in the control group received therapy with 200 mg adjuvant vaginal progesterone daily for 7 consecutive days after short cervix diagnosis.

Data Collection

Information was abstracted from the hospital maternal–fetal wards’ electronic medical record database; two review authors extracted the data, which were then checked for accuracy. Extracted data: patient characteristics; full-term and spontaneous preterm (GA of 20–36 weeks) delivery history; first-trimester pregnancy loss (GA of <14 weeks); history of uterine instrumentation (eg, dilatation and curettage or operative hysteroscopy), uterine anomalies, and assisted reproductive technology use; gestational age (GA) at first short cervix diagnosis and cerclage placement; chorionicity; pregnancy-related hypertensive disorders; gestational diabetes mellitus; other major maternal comorbidities (cancer or heart, kidney, liver, lung, and autoimmune diseases); GA at delivery; delivery mode; premature rupture of membranes (PPROM); intrauterine infection; placental abruption; birth weight; and neonatal intensive care unit (NICU) admission.

The patient GA was calculated during the first-trimester ultrasound examination, and chorionicity was determined via first-trimester ultrasound evaluation. The patient CL was determined by trained sonographers using a standardized TVU technique obtained at a GA of 16–28 weeks. Cervical length measurements were performed in the sagittal plane with the entire cervical canal visible, calipers placed on the internal and external os, with an empty bladder and minimal pressure. Three measurements were performed, and the shortest value was noted. The decision to perform cerclage was based on individual physician and patient preferences.

Outcome Measures

The primary outcome was a PTB rate at <34 weeks, and the secondary outcomes were PTB rates at <37 weeks, <28 weeks, and <32 weeks; perinatal mortality; birth weight; NICU admission; and low birth weight (<2500 g) and very low birth weight (<1500 g) rates.

The subgroup analysis was performed by stratifying women into the CL ≦15 mm subgroup and the CL >15 mm subgroup (CL measured via TVU). The subgroup analysis of women diagnosed with short cervix at a GA of ≦24 weeks and GA of >24 weeks was also planned. The corresponding outcomes were compared between the two groups.

Statistical Analysis

Normally distributed continuous variables were presented as mean ± standard deviation, and non-normally distributed continuous variables were presented as the median (interquartile range). Categorical variables were written as n (%). The chi-square test or Fisher’s exact test was used to assess the difference significance between groups for categorical variables, the Mann–Whitney U-test or non-parametric test was used for non-normally distributed continuous variables, and the t-test was used for normally distributed continuous variables.

A logistic regression was applied to control confounding variables and provide an adjusted odds ratio (OR) with a 95% confidence interval (CI). Unadjusted data were analyzed using crude ORs. In addition, the analysis of patient GA at delivery in each group was performed using the Kaplan–Meier (KM) method; the differences between the curves were assessed using the Log rank test. The Cox proportional hazards model was used to calculate the hazard ratio (HR) (CI = 95%) for GA at delivery.

All p values were two-sided, and a p value of <0.05 was considered statistically significant. The Statistical Package for Social Sciences (SPSS) 24.0 software (SPSS Inc., Chicago, IL, USA) was used to perform the statistical analysis.

Results

Patient Characteristics

A total of 320 women were enrolled in the present study. The women were divided into two groups: the UIC group (n = 187) and the control group (n = 133). Women in the UIC group underwent cerclage, and women in the control group were expectantly managed. A total of 2 patients underwent a re-cerclage due to ligation displacement. Technical success with no immediate procedure-related complications was achieved in all cerclage placements. The demographic characteristics of the two groups and the cervical length at the time of diagnosis are presented in Table 1.

Table 1

Demographic and Gestational Characteristics

Characteristics	UIC Group (n=187)	Control Group (n=133)	P value
Female age (years)	32.2±3.4	32.1±3.4	0.758
BMI (kg/m2)	26.1±3.2	25.1±2.7	0.081
Method of conception (n, %)			0.213
Natural conception	25 (13.37)	25 (18.80)
IVF/ICSI	162 (86.63)	108 (81.20)
Chorionicity (n, %)			0.109
DCDA	178 (95.19)	131 (98.50)
MCDA	9 (4.81)	2 (1.50)
Mode of delivery (n, %)			0.091
Natural birth	50 (26.74)	25 (18.80)
Forceps	2 (1.07)	1 (0.75)
Cesarean section	135 (72.19)	107 (80.45)
Maternal diseases (n, %)
Hypertensive disorder	12 (6.42)	10 (7.52)	0.823
Gestational diabetes mellitus	19 (10.16)	23 (17.29)	0.067
Others	8 (4.28)	9 (6.77)	0.449
Nulliparous	175 (93.58)	123 (92.48)	0.823
Previous first-trimester pregnancy losses
0	78 (41.71)	57 (42.86)	0.909
1	76 (40.43)	58 (42.34)	0.734
≧2	33 (17.55)	18 (13.14)	0.354
Cervical length (mm)	13.1±7.0	14.2±7.2	0.145

Abbreviations: BMI, body mass index; IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection; DCDA, dichorionic-diamniotic; MCDA, monochorionic-diamniotic.

Delivery and Neonatal Outcomes in All Short Cervix Twin Pregnancies

The delivery and neonatal outcomes of all cases with a short cervix are shown in Table 2. The comparisons between the UIC group and the control group showed comparable PTB rates at <34 weeks (50.80% vs 54.14%; OR = 0.88 [0.56–1.37]; and p = 0.572), <37 weeks (81.28 vs 84.21%; OR = 0.81 [0.45–1.47]; and p = 0.552), <32 weeks (36.90% vs 41.35%; OR = 0.82 [0.52–1.29]; and p = 0.485), and <28 weeks (12.30% vs 19.55%; OR = 0.58 [0.31–1.06]; and p = 0.084); comparable patient GA at delivery (32.49 ± 4.43 weeks vs 32.00 ± 4.97 weeks; p = 0.357); and no significant differences in perinatal mortality (14.17% vs 18.05%; p = 0.189), mean birth weight (1927 g vs 2150 g; p = 0.913), low infant birth weight rates (75.94% vs 80.45%; p = 0.178), and very low infant birth weight rates (32.09% vs 36.84%; p = 0.236). There were no significant differences in NICU admission among live-born neonates in the UIC group compared with the control group (47.35% vs 55.05%; p = 0.095). During labor, the incidence of PPROM was significantly lower in the UIC group than in the control group (21.93% vs 32.33%; OR = 1.70 [1.03–2.81]; and p = 0.040), and no difference of the incidence of intrauterine infection between the two groups (1.07% vs 0.75%; p = 0.771).

Table 2

Delivery and Neonatal Outcomes of Twin Pregnancies with a Short Cervix

Variable	UIC Group (n=187)	Control Group (n=133)	OR (95% CI)	P value
PTB<34 week	95 (50.80)	72 (54.14)	0.88 (0.56–1.37)	0.572
PTB<37 week	152 (81.28)	112 (84.21)	0.81 (0.45–1.47)	0.552
PTB<32 week	69 (36.90)	55 (41.35)	0.82 (0.52–1.29)	0.485
PTB<28 week	23 (12.30)	26 (19.55)	0.58 (0.31–1.06)	0.084
PPROM (n, %)	41 (21.93)	43 (32.33)	1.70 (1.03–2.81)	0.040*
Intrauterine infection (n, %)	2 (1.07)	1 (0.75)	0.70 (0.06–7.80)	0.771
GA at delivery (week)	32.49±4.43	32.00±4.97		0.357
Perinatal mortality (n, %)	53 (14.17)	48 (18.05)	1.33 (0.87–2.04)	0.189
Birth weight (g)	1927 (1320, 2460)	2150 (1266, 2395)		0.913
LBW<2500 g	284 (75.94)	214 (80.45)	0.77 (0.52–1.13)	0.178
VLBW<1500 g	120 (32.09)	98 (36.84)	0.81 (0.58–1.13)	0.236
Admission to NICU (born alive only)	152/321(47.35)	120/218 (55.05)	1.36 (0.96–1.92)	0.095

Note: *P < 0.05.

Abbreviations: OR, odds ratio; CI, confidence interval; PPROM, premature rupture of membranes; PTB, preterm birth; GA, gestational age; LBW, low birth weight; VLBW, very low birth weight; NICU, neonatal intensive care unit.

Logistic Regression Analysis for PTB Risk at <34 Weeks

Univariate regression analysis demonstrated that short cervix diagnosis time (crude OR = 0.21; CI = 95% [1.12–1.30]), and cervical length (crude OR = 1.11; CI = 95% [1.08–1.15]) were the risk factors for PTB at <34 weeks (Table 3).

Table 3

Logistic Regression Analysis for PTB Risk at <34 Weeks

Variables	Crude OR (95% CI)	P value	Adjusted OR (95% CI)	P value
Cerclage or not	0.83 (0.53–1.29)	0.398	0.20 (0.06–0.66)	0.008*
Diagnosis time for short cervix	0.21 (1.12–1.30)	0.000*	1.39 (1.18–1.64)	0.000*
Cervical length	1.11 (1.08–1.15)	0.000*	1.15 (1.07–1.24)	0.001*
Female age	1.06 (1.00–1.13)	0.055	1.09 (0.97–1.22)	0.160
Body mass index	0.99 (0.87–1.13)	0.854	1.12 (0.93–1.35)	0.229
Method of pregnancy	1.91 (0.94–3.88)	0.074	1.44 (0.49–4.23)	0.513
Maternal diseases	0.75 (0.45–1.28)	0.293	0.35 (0.11–1.15)	0.083
Nulliparous	2.07 (0.82–5.23)	1.222	0.40 (0.07–2.44)	0.318
Previous first-trimester pregnancy losses	0.77 (0.49–1.20)	0.242	1.61 (0.65–3.97)	0.305

Note: *P < 0.05.

Abbreviations: OR, odds ratio; CI, confidence interval.

A multivariate logistic regression analysis demonstrated that cerclage administration (adjusted OR = 0.20; CI = 95% [0.06–0.66]), short cervix diagnosis time (adjusted OR = 1.39; CI = 95% [1.18–1.64]), and cervical length (adjusted OR = 1.15; CI = 95% [1.07–1.24]) were the independent risk factors for PTB at <34 weeks (Table 3).

Delivery and Neonatal Subgroup Analysis Outcomes

The subgroup analysis delivery outcomes of twin pregnancies are shown in Table 4, and the subgroup analysis of neonatal outcomes are shown in Table 5.

Table 4

Subgroup Analysis Delivery Outcomes of Twin Pregnancies

	UIC Group	Control Group	OR (95% CI)	P value
Subgroup 1: According to cervical length
PTB<34 week
CL≦15 mm	62/102 (60.78)	54/69 (78.26)	0.43 (0.22–0.86)	0.020*
CL>15 mm	33/85 (38.82)	18/64 (28.13)	1.62 (0.81–3.26)	0.222
PTB<37 week
CL≦15 mm	87/102 (85.29)	65/69 (94.20)	0.36 (0.11–1.13)	0.084
CL>15 mm	65/85 (76.47)	47/64 (73.43)	1.18 (0.56–2.48)	0.705
PTB< 32 week
CL≦15 mm	46/102 (45.10)	44/69 (63.77)	0.47 (0.25–0.87)	0.019*
CL>15 mm	23/85 (27.06)	11/64 (17.19)	1.79 (0.80–4.00)	0.172
PTB< 28 week
CL≦15 mm	15/102 (14.71)	21/69 (30.43)	0.39 (0.19–0.84)	0.021*
CL>15 mm	8/85 (9.41)	5/64 (7.81)	1.23 (0.38–3.94)	0.732
GA at delivery (week)
CL≦15 mm	31.55±4.48	30.09±4.84		0.034*
CL>15 mm	33.63±4.12	34.14±4.17		0.452
Subgroup 2: According to GA at diagnosis of short cervix
PTB< 34 week
GA≦24 week	84/143 (61.54)	51/59 (84.75)	0.29 (0.13–0.63)	0.001*
GA>24 week	11/44 (20.45)	21/74 (32.43)	0.54 (0.22–1.29)	0.205
PTB< 37 week
GA≦24 week	119/143 (83.21)	57/59 (96.61)	0.17 (0.04–0.76)	0.010*
GA>24 week	33/44 (75)	55/74 (74.32)	1.04 (0.44–2.45)	0.935
PTB< 32 week
GA≦24 week	61/143 (46.15)	44/59 (74.58)	0.29 (0.15–0.57)	0.000*
GA>24 week	8/44 (18.18)	11/74 (13.51)	1.27 (0.47–3.46)	0.796
PTB< 28 week
GA≦24 week	22/143 (18.18)	24/59 (38.98)	0.35 (0.18–0.68)	0.003*
GA>24 week	1/44 (4.55)	2/74 (2.70)	0.84 (0.07–9.51)	0.886
GA at delivery (week)
GA≦24 week	31.75±4.57	28.20±4.99		0.000*
GA>24 week	34.73±3.08	34.91±2.43		0.722

Note: *P < 0.05.

Abbreviations: OR, odds ratio; CI, confidence interval; PTB, preterm birth; CL, cervical length; GA, gestational age.

Table 5

Subgroup Analysis Neonatal Outcomes of Twin Pregnancies

	UIC Group	Control Group	OR (95% CI)	P value
Subgroup 1: According to cervical length
Perinatal mortality (n, %)
CL≦15 mm	31/204 (15.20)	35/138 (25.36)	1.90 (1.10–3.26)	0.025*
CL>15 mm	22/170 (12.94)	13/128 (10.16)	0.76 (0.37–1.57)	0.586
Birth Weight (g)
CL≦15 mm	1735±746	1520±824		0.021*
CL>15 mm	1960±777	2098±761		0.126
Low birth weight (<2500g)
CL≦15 mm	165/204 (80.88)	128/138 (92.75)	0.33 (0.16–0.69)	0.003*
CL>15 mm	119/170 (70)	86/128 (67.19)	1.14 (0.70–1.87)	0.616
Very low birth weight (<1500 g)
CL≦15 mm	80/204 (39.22)	74/138 (53.62)	0.56 (0.36–0.86)	0.011*
CL>15 mm	40/170 (23.53)	24/128 (18.75)	1.33 (0.76–2.35)	0.393
Admission to NICU (born alive only)
CL≦15 mm	97/173 (56.07)	75/103 (72.82)	2.10 (1.24–3.56)	0.007*
CL>15 mm	55/148 (37.16)	45/115 (39.13)	1.09 (0.66–1.80)	0.798
Subgroup 2: According to GA at diagnosis of short cervix
Perinatal mortality (n, %)
GA≦24 week	49/286 (17.13)	46/118 (38.98)	2.01 (1.27–3.18)	0.004*
GA>24 week	4/88 (4.55)	2/148 (1.35)	0.29 (0.05–1.60)	0.132
Birth Weight (g)
GA≦24 week	1792 (1251, 2391)	1200 (450, 1930)		0.000*
GA>24 week	2405 (1800, 2723)	2325 (2181, 2555)		0.973
Low birth weight (<2500 g)
GA≦24 week	232/286 (81.12)	110/118 (93.22)	0.32 (0.15–0.70)	0.002*
GA>24 week	52/88 (59.09)	104/148 (70.27)	0.61 (0.35–1.06)	0.089
Very low birth weight (<1500 g)
GA≦24 week	106/286 (37.06)	84/118 (71.19)	0.24 (0.15–0.38)	0.000*
GA>24 week	14/88 (15.91)	14/148 (9.46)	1.81 (0.82–4.00)	0.150
Admission to NICU (born alive only)
GA≦24 week	122/237 (51.48)	52/72 (72.22)	2.45 (1.38–4.36)	0.002*
GA>24 week	30/84 (35.71)	68/146 (46.58)	1.57 (0.90–2.73)	0.128

Note: *P < 0.05.

Abbreviations: OR, odds ratio; CI, confidence interval; CL, cervical length; NICU, neonatal intensive care unit; GA, gestational age.

A total of 102 women in the UIC group and 69 women in control group were included in the subgroup analysis for women with a CL of ≦15 mm. PTB rates at <34 weeks (60.78% vs 78.26%; OR = 0.43; CI = 95% [0.22–0.86]; and p = 0.020), <32 weeks (45.10% vs 63.77%; OR = 0.47 [0.25–0.87]; and p = 0.019), and <28 weeks (14.71% vs 30.43%; OR = 0.39 [0.19–0.84]; and p = 0.021), were significant lower in the UIC group than in the control group. There was no significant difference in the PTB rate at <37 weeks between the two groups. The patient GA at delivery was longer in the UIC group than in the control group (31.55 ± 4.48 weeks vs 30.09 ± 4.84 weeks), and the mean birth weight was significantly higher in the UIC group than in the control group (1735 ± 746 g vs 1520 ± 824 g; p = 0.021). Perinatal mortality (15.20% vs 25.36%; p = 0.025), the rates of low infant birth weight (80.88% vs 92.75%; p = 0.003) and very low infant birth weight (39.22% vs 53.62%; p = 0.011), and NICU admission (56.07% vs 72.82%; p = 0.007) were significant lower in UIC group than in the control group.

In women with a CL of ≦15 mm, the KM analysis showed a significantly higher cumulative incidence of successful delivery in the cerclage group than in the control group (log rank test, x2 = 5.74, p = 0.017; HR = 1.55, CI = 95% [1.08–2.24], p = 0.018) (Figure 2A).

Figure 2

KM curves generated from CL subgroup analysis. Proportion KM curves in women with twin pregnancy and a short cervix with no delivery across gestation and treated with cervical cerclages (UIC group) compared with the expectant management (control group). CL-based subgroup analysis; (A) showed a CL of ≦15 mm, and (B) showed a CL of >15 mm. Group comparison using the Log rank test showed a significant difference (HR = 1.55; CI = 95% [1.08–2.24]; and p = 0.018) in (A), with no difference between the two groups in (B). Red curve cases with a short cervix treated with ultrasound-indicated cerclage; blue curve cases with expectant management.

A total of 85 women in UIC group and 64 women in control group had a CL of >15 mm. PTB rates at <34 weeks, <37 weeks, <32 weeks, and <28 weeks were comparable between groups. Perinatal mortality (12.94% vs 10.16%; p = 0.586), low birth weight rate (70% vs 67.19%; p = 0.616), very low birth weight rate (23.53% vs 18.75%; p = 0.393), and NICU admission (37.16% vs 39.13%; p = 0.798) in the two groups were also similar. There were no significant differences in GA at delivery (33.54 ± 4.17 weeks vs 34.03 ± 4.28 weeks; p = 0.489) and birth weight (1960 ± 777 g vs 2098 ± 761 g; and p = 0.126) between the two groups. The KM analysis in the CL >15 mm subgroup showed no significant difference in the cumulative number of successful deliveries in the cerclage group compared with the control group (log rank test, x2 = 1.76; p = 0.185) (Figure 2B).

A total of 143 women in the UIC group and 59 women in control group had a first short cervix diagnosis time of GA ≦ 24 weeks; here, the PTB rates at <34 weeks (61.54% vs 84.75%; OR = 0.29 [0.13–0.63]; and p = 0.001), <37 weeks (83.21% vs 96.61%; OR = 0.17 [0.04–0.76]); and p = 0.010), <32 weeks (46.15% vs 74.58%; OR = 0.29 [0.15–0.57]; and p = 0.000), and <28 weeks (18.18% vs 38.98%; OR = 0.35 [0.18–0.68]; and p = 0.003) were significantly lower in UIC group compared with the control group. The GA at delivery (31.75 ± 4.57 weeks vs 28.20 ± 4.99 weeks; p = 0.000) and the diagnose-to-delivery interval (11.01 ± 4.82 weeks vs 6.98 ± 3.84 weeks; p = 0.000) were longer in the UIC group compared with the control group. Moreover, the median birth weight was heavier in UIC group compared with the control group (1792 g vs 1200 g; p = 0.000). However, perinatal mortality (17.13% vs 38.98%; p = 0.000) as well as the rates of low birth weight (81.12% vs 93.22%; p = 0.002) and very low birth weight (37.06% vs 71.19%; p = 0.000), and NICU admission (51.48% vs 72.22%; p = 0.002) were lower in UIC group compared with the control group. The KM analysis in the present patient subgroup showed a significantly higher cumulative incidence of successful deliveries in the UIC group compared with the control group (log rank test, x2 = 23.05, p = 0.000; HR = 2.29, CI = 95% [1.61–3.26], and p = 0.000) (Figure 3A).

Figure 3

KM curves generated from subgroup analysis of first short cervix diagnosis GA. Proportion KM curves in twin pregnancies in women with twin pregnancy and a short cervix with no delivery across gestation, treated with cervical cerclages (UIC group) compared with women with expectant management (control group). Subgroup analysis according to the first short cervix diagnosis GA; (A) Showed a GA of ≦24 weeks, and (B) showed a GA of >24 weeks. Group comparison using the Log rank test showed a significant difference (HR = 2.29; CI = 95% [1.61–3.26]); and p = 0.000) in (A) and no difference between in (B). Red curve cases with cerclage, blue curve cases with management treatment.

A total of 44 women in the UIC group and 74 women in control group had a short cervix diagnosis time of >24 weeks; here, the PTB rates at <34 weeks, <37 weeks, <32 weeks, and <28 weeks were comparable between the two groups. Perinatal mortality (4.55% vs 1.35%; p = 0.132) as well as the rates of low birth weight (59.09% vs 70.27%; p = 0.089), very low birth weight (15.91% vs 9.46%; p = 0.150), and NICU admission (35.71% vs 46.58%; p = 0.128) in the two groups were also similar. There were no significant differences in the GA at delivery (34.73 ± 3.08 weeks vs 34.91 ± 2.43 weeks; p = 0.722) and the median birth weight (2405 g vs 2325 g; p = 0.973) between the two groups. The KM analysis in the present subgroup showed no significant difference in the cumulative number of successful deliveries in the UIC group compared with the control group (log rank test, χ2 = 0.07; p = 0.785) (Figure 3B).

Discussion

The present retrospective study evaluated UIC efficacy in asymptomatic twin gestations with second trimester TVU screening. No differences were found in the PTB rate (<34 weeks) or the delivery and neonatal outcomes in the comparison of women with twin pregnancy and a short cervix undergoing UIC and women with no intervention. However, UIC had a significant effect on reducing the PTB rate, and the neonatal outcome was significantly improved in women with a CL of ≤15 mm and a short cervix diagnosis time of GA ≦ 24 weeks compared with women who were expectantly managed.

It is well accepted that women with twin pregnancies have a high risk of spontaneous PTB; especially in women with a short cervix.7 Therefore, preventing spontaneous PTB in twin pregnancy poses a challenging clinical dilemma for both patients and physicians. Cervical cerclage has been used to prolong pregnancy and prevent morbidity and mortality associated with premature birth for nearly half a century.8 Many studies have proven that cerclage is effective in PTB prevention in singleton pregnancy.2 However, no definite statement has been made on whether cerclage is effective in PTB prevention in twin pregnancy.

Certain studies on UIC in twin gestation10–14 show negative results in women with a CL of ≦25 mm. Han et al11 compared 96 women in the cerclage group with 39 women in control group (GA of 14–26 weeks); no significant differences were detected in the overall PTB rates at <32 weeks (15% vs 11.1%; p = 0.691) and <34 weeks (30% vs 22.2%; p = 0.536). Saccone’s study,12 which included three trials with 49 women who had twin gestations and a short CL, showed no statistically significant differences in the PTB rates at <34 weeks (adjusted OR [aOR] = 1.17; CI = 95% [0.23–3.79]; p > 0.05) between the cerclage group and the no cerclage group. A meta-analysis13 including 23 trials and comprising 6626 women with twin pregnancies found that cerclage use could not significantly reduce neonatal death or the overall PTB risk at a GA of <34 weeks or <37 weeks. In Adams’s research,14 43 patients received cerclage and 39 did not; patients with a CL of ≦25 mm in the cerclage group showed no reduction in PTB rate at <35 weeks compared with the no cerclage group. A subsequent Cochrane review15 published in 2014 examined five trials, two of which (n = 73 women) assessed history-indicated cerclage and three of which (n = 55 women) assessed ultrasound-indicated cerclage. The review found no benefit of UIC in reducing preterm delivery in twin pregnancies at a GA of <34 weeks (Relative Risk [RR] = 1.16; CI = 95% [0.44–3.36]; four trials, n = 98). There was no reduction in the adverse neonatal outcome composite (RR = 1.54; CI = 95% [0.58–4.11]). The authors concluded that there was no evidence regarding the usefulness of UIC in PTB risk reduction in twin gestation; however, further research was required due to the small trial number, each of which had a low number of patients. In the present study’s overall sample comparison, UIC use in women with a CL of <25 mm and twin gestation did not decrease the PTB rate at <34 weeks when compared with patients who were managed expectantly. Meanwhile, the subgroup analysis showed a significantly decreased PTB rate at <34 weeks and improved perinatal outcomes in the UIC group compared with the control group in women with a short cervix of ≦15 mm or first short cervix diagnosis GA of ≦24 weeks. A CL of <25 mm is considered the standard in singleton pregnancy cerclage placement indications; however, it is unclear whether 25 mm or 15 mm is the appropriate indication for twin gestation.

Certain studies supported our view that UIC is useful in women with twin pregnancy and a CL of ≦15 mm. Roman et al16 compared 32 cases who underwent UIC and 39 cases who did not undergo UIC; all cases had a CL of ≦15 mm at a GA of <24 weeks. Here, the PTB rate at <34 weeks was significantly decreased (50% vs 79.5%, aOR = 0.51; CI = 95% [0.31–0.83]) and pregnancy prolonged (12.5 ± 4.5 weeks vs 8.8 ± 4.6 weeks; p < 0.001) in the UIC group when compared with the control group.16 In their research,14 Adams et al reported a significantly decreased PTB risk at <35 weeks (37% vs 71.4%; adjusted RR = 0.49 [0.26–0.93]) in patients with a CL of <15 mm. Furthermore, a recent meta-analysis conducted by Chunbo Li showed that cerclage placement in women with twin pregnancy and a CL of <15 mm was associated with significant pregnancy prolongation by a mean difference of 3.89 weeks of gestation (CI = 95% [2.19–5.59]; p = 0.000; and I2 = 0%) and a PTB risk reduction at <34 weeks of gestation (RR = 0.57; CI = 95% CI [0.43–0.75]; p = 0.000; and I2 = 0%).17 Houlihan’s retrospective cohort study on consecutive diachronic diamniotic (DCDA) twin gestation in women with a short cervix at a GA of 16–24 weeks showed that the primary outcome PTB at <32 weeks was significantly lower in 40 cerclage cases than in 40 control cases (20% vs 50%; RR = 0.40; and CI = 95% [0.20–0.80]).18 A retrospective cohort study on DCDA twin pregnancy in women with a short CL (25 mm) that included 33 cerclage cases and 13 non-cerclage cases found that the gestational age of delivery was significantly longer in the cerclage group than in the non-cerclage group (86.09 ± 41.32 days vs 52.31 ± 33.24 days; p = 0.014). Moreover, the PTB rate at <34 weeks in the cerclage group decreased significantly (19.0% vs 85.7%; p = 0.003). UIC in DCDA twin pregnancy can decrease the PTB rate and prolong the gestational age of delivery.19

In a study on PTB risk factors in twins, an ultrasound-measured CL of <25 mm at a GA of 24 weeks was noted as the strongest PTB predictor.19–23 In women with twin pregnancies, the risk of spontaneous PTB also increases with decreasing CL.6 Women with twin pregnancies and a short cervix are at extremely high risk for PTB.7 In the present research, the effect of cerclage placement on PTB rate reduction was significantly different at ≦24 weeks and at >24 weeks. It was found that, in women with twin gestation and a short cervix diagnosed at a GA of ≦24 weeks, cerclage placement had an overall beneficial effect on PTB rate reduction at <34 weeks as well as neonatal outcome improvement when compared with expectant management. However, in patients diagnosed at a GA of >24 weeks, the results in the two groups were comparable. Twins are the high-risk population for premature birth, and CL monitoring for this population should be strengthened. However, CL monitoring in twin pregnancy is not a routine practice in China. Based on the present data combined with the results of other studies, routine CL measurement during screening for Down’s syndrome at a GA of 11–14 weeks as well as during screening for fetal macro malformations at a GA of 18–22 weeks (20–24 weeks in China) is suggested.

The present study has several limitations. In present research neonatal outcome data were not all compiled, only birth weight and NICU admission rate were concluded, and other variables, such as intraventricular hemorrhage, necrotizing enterocolitis, neonatal sepsis, retinopathy of prematurity, bronchopulmonary dysplasia, periventricular leukomalacia, or use of mechanical ventilation were out of collection. Therefore, studies on the neonates in the UIC and control groups are not comprehensive. As a short TVU-detected CL has been shown as a good PTB predictor in twin pregnancy, the present study used the length as the only indicator. In addition to the CL, the dilated diameter and elastic value of the cervix are also parameters reflecting cervix function. Several studies11,16 have confirmed that cervical dilation (especially >1 cm) and treatment with cervical cerclage may reduce the PTB rate in twin gestation. Several new parameters, such as elasticity and cervical dilation, will be applied in future studies on twin pregnancy.

In conclusion, the results of the present research demonstrated that UIC performance in women with twin pregnancy does not improve the maternal and neonatal outcomes. However, in women with a very short cervix (≦15 mm) or short cervix diagnosed at a GA of ≦24 weeks, UIC performance may significantly reduce the PTB rate at <34 weeks as well as perinatal morbidity and mortality.